Efficacy and mechanism of sub-sensory sacral (optimised) neuromodulation in adults with faecal incontinence: study protocol for a randomised controlled trial

Background Faecal incontinence (FI) is a substantial health problem with a prevalence of approximately 8% in community-dwelling populations. Sacral neuromodulation (SNM) is considered the first-line surgical treatment option in adults with FI in whom conservative therapies have failed. The clinical...

Full description

Saved in:
Bibliographic Details
Published in:Current controlled trials in cardiovascular medicine Vol. 19; no. 1; pp. 336 - 19
Main Authors: McAlees, Eleanor, Vollebregt, Paul F., Stevens, Natasha, Dudding, Tom C., Emmanuel, Anton V., Furlong, Paul L., Hamdy, Shaheen, Hooper, Richard L., Jones, James F. X., Norton, Christine, O’Connell, P. Ronan, Scott, S. Mark, Knowles, Charles H.
Format: Journal Article
Language:English
Published: London BioMed Central 26.06.2018
BioMed Central Ltd
Springer Nature B.V
BMC
Subjects:
Adolescent
Adult
Adults
Aged
Analysis
Behavior modification
Biomedicine
Care and treatment
Clinical trials
Costs
Cross-Over Studies
Defecation
Double-Blind Method
Electric stimulation therapy
Evoked potential
Faecal incontinence
FDA approval
Fecal incontinence
Fecal Incontinence - diagnosis
Fecal Incontinence - physiopathology
Fecal Incontinence - therapy
Female
Germany
Health aspects
Health Sciences
Humans
Hypotheses
Incontinence
Ireland
Lumbosacral Plexus
Magneticoencepholograpy
Male
Medicine
Medicine & Public Health
Middle Aged
Multicenter Studies as Topic
Neurophysiology
Older people
Pathophysiology
Patients
Randomised controlled trial
Randomized Controlled Trials as Topic
Recovery of Function
Regulatory approval
Sacral nerve stimulation
Sacral neuromodulation
Statistics for Life Sciences
Study Protocol
Time Factors
Transcutaneous Electric Nerve Stimulation - methods
Treatment Outcome
United Kingdom
Young Adult
United Kingdom
Ireland
Germany
United States > US
Faecal incontinence
Magneticoencepholograpy
Evoked potential
Sacral neuromodulation
Randomised controlled trial
Anorectal manometry
Sacral nerve stimulation
ISSN:1745-6215, 1745-6215
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Faecal incontinence (FI) is a substantial health problem with a prevalence of approximately 8% in community-dwelling populations. Sacral neuromodulation (SNM) is considered the first-line surgical treatment option in adults with FI in whom conservative therapies have failed. The clinical efficacy of SNM has never been rigorously determined in a trial setting and the underlying mechanism of action remains unclear. Methods/design The design encompasses a multicentre, randomised, double-blind crossover trial and cohort follow-up study. Ninety participants will be randomised to one of two groups (SNM/SHAM or SHAM/SNM) in an allocation ratio of 1:1. The main inclusion criteria will be adults aged 18–75 years meeting Rome III and ICI definitions of FI, who have failed non-surgical treatments to the UK standard, who have a minimum of eight FI episodes in a 4-week screening period, and who are clinically suitable for SNM. The primary objective is to estimate the clinical efficacy of sub-sensory SNM vs. SHAM at 32 weeks based on the primary outcome of frequency of FI episodes using a 4-week paper diary, using mixed Poisson regression analysis on the intention-to-treat principle. The study is powered (0.9) to detect a 30% reduction in frequency of FI episodes between sub-sensory SNM and SHAM stimulation over a 32-week crossover period. Secondary objectives include: measurement of established and new clinical outcomes after 1 year of therapy using new (2017 published) optimised therapy (with standardised SNM-lead placement); validation of new electronic outcome measures (events) and a device to record them, and identification of potential biological effects of SNM on underlying anorectal afferent neuronal pathophysiology (hypothesis: SNM leads to increased frequency of perceived transient anal sphincter relaxations; improved conscious sensation of defaecatory urge and cortical/subcortical changes in afferent responses to anorectal electrical stimulation (main techniques: high-resolution anorectal manometry and magnetoencephalography). Discussion This trial will determine clinical effect size for sub-sensory chronic electrical stimulation of the sacral innervation. It will provide experimental evidence of modifiable afferent neurophysiology that may aid future patient selection as well as a basic understanding of the pathophysiology of FI. Trial registration International Standard Randomised Controlled Trial Number: ISRCTN98760715 . Registered on 15 September 2017.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Undefined-1
content type line 23
ISSN:1745-6215
1745-6215
DOI:10.1186/s13063-018-2689-1